Specimen Transport
Articles & Testing Guides
Education
Outreach Resource Center
- Support Services
- Operations
- Sales and Marketing
- Billing and Finance
- Regulatory
- Examples
- More Resources
- Contact Outreach Team
| Web: | MayoMedicalLaboratories.com |
|---|---|
| Email: | mml@mayo.edu |
| Telephone: | 800.533.1710 |
| International: | 507.266.5700 |
| Values are valid only on day of printing. | |
Biochemical diagnosis of selected inborn errors of metabolism
(see below) by quantitative determination of target urinary metabolites
that are present in amounts below the detection limit of routine organic
acid analysis.
Acylglycine analysis is the method of choice, in urine, for the
biochemical evaluation of asymptomatic patients affected with 1 of
the following inborn errors of metabolism:
-Short chain acyl-CoA dehydrogenase (SCAD) deficiency
-Functional SCAD deficiency (G625A, C611T variants)
-Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency
-Medium-chain 3-ketoacyl-CoA thiolase (MCKAT) deficiency
-Electron transfer flavoprotein (ETF) deficiency (Glutaric acidemia type 2)
-ETF: ubiquinone oxidoreductase (ETF-QO) deficiency
(Glutaric acidemia type 2)
-Riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency
-Ethylmalonic encephalopathy
-2-Methylbutyryl-CoA dehydrogenase deficiency
-Isovaleryl-CoA dehydrogenase deficiency
-Glutaryl-CoA dehydrogenase deficiency
Glycine conjugates (acylglycines) of acyl CoA species, which are
normal intermediates of amino acid and fatty acid metabolism, are
informative biochemical markers of selected inborn errors of
metabolism.
The biochemical diagnosis of these disorders is a complex process
that cannot be achieved by a single test and requires the performance
of multiple analyses and their integrated interpretation. While a major
acylglycine accumulation may be detected by organic acid analysis
(#80619 "Organic Acids Screen, Urine"), especially when the specimen
is collected during an acute illness, asymptomatic patients may
demonstrate mild and intermittent biochemical phenotypes that are
likely to be missed by standard urine organic acid analysis. The
quantitative analysis of urinary acylglycines by stable isotope dilution
gas chromatography/mass spectrometry (GC-MS) is a more sensitive
and specific method and is particularly effective for identifying
asymptomatic patients affected with 1 of the disorders listed below.
Control Values
Results Expressed as ug/mg Creatinine
Range
Ethylmalonic Acid 0.5-20.2
2-Methylsuccinic Acid 0.4-13.8
Glutaric Acid 0.6-15.2
Isobutyrylglycine 0.00-11.0
n-Butyrylglycine 0.1-2.1
2-Methylbutyrylglycine 0.3-7.5
Isovalerylglycine 0.3-14.3
n-Hexanoylglycine 0.2-1.9
n-Octanoylglycine 0.1-2.1
3-Phenylpropionylglycine 0.00-1.1
Suberylglycine 0.00-11.0
trans-Cinnamoylglycine 0.2-14.7
Dodecanedioic Acid (12:0) 0.00-1.1
Tetradecanedioic Acid (14:0) 0.00-1.0
Hexadecanedioic Acid (16:0) 0.00-1.0
When abnormal results are detected, a detailed interpretation
is given, including an overview of the results and of their significance;
a correlation to available clinical information; elements of differential
diagnosis; recommendations for additional biochemical testing and
in vitro confirmatory studies (enzyme assay, molecular analysis); name
and phone number of key contacts who may provide these studies
at Mayo or elsewhere; and a phone number to reach one of the
laboratory directors in case the referring physician has additional
questions.
Due to the limited number of metabolites included in the acylglycine
analysis, it is recommended that an #80619 "Organic Acids Screen,
Urine" also be performed concurrently.
1. Rinaldo P, O'Shea JJ, Coates PM, et al: Medium-chain Acyl-CoA
dehydrogenase deficiency. Diagnosis by stable-isotope dilution
measurment of urinary n-hexanoylglycine and 3-phenylpropionyl-
glycine. N Engl J Med 1988;319:1308-1313
2. Rinaldo P, Welch RD, Previs SF, et al: Ethylmalonic/adipic
aciduria: effect of oral medium-chain triglycerides, carnitine, and
glycine on urinary excretion of organic acids, acylcarnitines, and
acylglycines. Pediatr Res 1991;30:216-221
3. Gibson KM, Terry G, Burlingame TG, et al: 2-Methylbutyryl-coenzyme
A dehydrogenase deficiency: a new inborn error of L-isoleucine
metabolism. Pediatr Res 2000;47:830-833
4. Rinaldo P: Laboratory diagnosis of inborn errors of metabolism.
In Liver Disease in Children. 2nd edition. Edited by FJ Suchy.
Philadelphia, Lippincott, Williams & Wilkins, 2001, pp 171-184
5. Corydon MJ, Vockley G, Rinaldo P, et al: Role of common variant
alleles in the molecular basis of short-chain acyl-CoA
dehydrogenase deficiency. Pediatr Res 2001;49:18-23